Skip to main content
Equibles

CITIGROUP INC

Position in EBS — Emergent BioSolutions Inc.

CIK 831001 NEW YORK, NY
Back to EBS Full portfolio

Position in EBS

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$552,409
+$444,103 QoQ
Shares Held
65,920
+405.2% QoQ
Ownership
0.129%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#63
of 194 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in EBS Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

CITIGROUP INC holds $573,447,136 across 59 Drug Manufacturers - Specialty & Generic names. EBS ranks #34 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 UTHR
UNITED THERAPEUTICS Corp
 262,200 $142,067,824
2 ZTS
Zoetis Inc.
 1,265,210 $90,917,989
3 TEVA
Teva Pharmaceutical Industries Ltd
 2,527,031 $85,615,809
4 VTRS
Viatris Inc
 4,360,444 $69,243,850
5 NBIX
Neurocrine Biosciences Inc
 179,076 $30,181,467
6 INDV
Indivior Pharmaceuticals, Inc.
 643,006 $26,382,535
7 LNTH
Lantheus Holdings, Inc.
 189,692 $21,044,429
8 HLN
Haleon plc
 1,507,538 $14,065,329

All Filings in EBS

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $552,409 65,920
2026-03-31 $108,306 13,049
2025-12-31 $138,937 11,241
2025-09-30 $34,503 3,912
2025-06-30 $218,125 34,189
2025-03-31 $423,712 87,184
2024-12-31 $817,560 85,519
2024-09-30 $330,977 39,638
2024-06-30 $149,569 21,931
2024-03-31 $31,287 12,367
2023-12-31 $18,201 7,584
2023-09-30 $51,230 15,068
2023-06-30 $1,425,825 193,990
2023-03-31 $3,391,438 327,359
2022-12-31 $2,467,853 208,963
2022-09-30 $4,918,396 234,321
2022-06-30 $4,644,266 149,622
2022-03-31 $2,674,648 65,140
2021-12-31 $5,926,221 136,329
2021-09-30 $2,030,688 40,557
2021-06-30 $6,397,137 101,558
2021-03-31 $5,077,903 54,654
2020-12-31 $2,559,871 28,570
2020-09-30 $1,731,706 16,759
2020-06-30 $8,880,367 112,296
2020-03-31 $1,923,382 33,242